PE LIFELAB STUDIOS RFP 250031 AMD 3.PDF

Maricopa County — Formal (2026-11-18)

View PDF Item 81 Meeting page

Extracted text (via pymupdf_layout) 7513 characters
C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
AMENDMENT TO CONTRACT PH RFP 250031
BETWEEN MARICOPA COUNTY
BY AND THROUGH ITS
DEPARTMENT OF PUBLIC HEALTH
AND LIFELAB STUDIOS INC.
I. The purpose of this amendment is to add additional funding from the Overdose Data
to Action (OD2A) grant received by the Centers for Disease Control and Prevention
(CDC) and administered by the Maricopa County Department of Public Health. The
contract is currently funded with Opioid Settlement Funds (OSF), also administered by
the Maricopa County Department of Public Health.
II. The above-named contract is hereby amended as specified below:
A. Exhibit B-2 -YEAR 2 BUDGET SHEET & BUDGET NARRATIVE, shall be revised to
include Exhibit B-2 Addendum - Year 2 Overdose Data to Action (OD2A) Budget
Sheet & Narrative (November 18, 2026 to March 31, 2027), which appears
beginning on page 3 of this amendment. This additional amount constitutes the
Overdose Data to Action (OD2A) portion that is being added for Year 2.
B. Exhibit A – PRICING AND RESPONDENT INFORMATION shall be updated to add
an additional $130,000 of Overdose Data to Action (OD2A) Funding for the Year 2
budget period to begin November 18, 2026 to March 31, 2027, making the total
not-to-exceed amount $530,409.
C. SECTION 4.0 AVAILABILITY OF FUNDS shall be updated with the following
language:
“4.3 All Overdose Data to Action (OD2A) Funds identified in Exhibit B-2, Year 2
Budget Sheet and Narrative, shall be expended within the budget period specified
therein. Federal funds identified in the budget may be carried forward at the
discretion of the Maricopa County Department of Public Health to the extent
permitted by the funding agency.”
D. Exhibit D-2, SCOPE OF WORK shall be replaced with Exhibit D-3, Revised Year 2
Scope of Work (November 18, 2026 – March 31, 2027), which begins on page 6
of this document. This updated scope of work includes deliverables from both
funding sources.
E. Exhibit L, Unallowable Activities and Expenditures, has been newly added and
begins on page 11. It pertains to the newly added Overdose Data to Action
(OD2A) funding.
F. Exhibit M, Notice of Award, has been newly added and begins on page 13. This is
the award information that pertains to the newly added Overdose Data to Action
(OD2A) funding.
Page 1 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
III. All other terms and conditions of the contract shall remain in full force and effect.
IN WITNESS WHEREOF, the parties agree to the changes indicated herein:
FOR AND ON BEHALF OF FOR AND ON BEHALF OF
MARICOPA COUNTY LIFELAB STUDIOS, INC.
By: By:
Chair, Board of Supervisors Lifelab Studios, Inc.
10/15/2026
Date Date
ATTEST
Clerk of the Board
Date
APPROVED AS TO FORM
Attorney for Maricopa County
Date
Page 2 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Exhibit B-2 Addendum
Year 2 OD2A Budget Sheet & Narrative
November 18, 2026 – March 31, 2027
Page 3 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 4 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 5 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Exhibit D-3,
Revised Year 2 Scope of Work
(November 18, 2026 – March 31,
2027)
Page 6 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 7 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 8 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 9 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 10 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Exhibit L
UNALLOWABLE ACTIVITIES AND
EXPENDITURES
This document is to give an overview of general unallowable activities and expenditures related
to overdose prevention under OD2A: LOCAL. While some of the activities listed below may
contribute to overdose prevention in some manner, they are either not allowed by HHS, CDC, or
congressional appropriations language. This is not an exhaustive list.
Activities related to harm reduction:
• Establish a new Syringe Services Program (SSPs)
• Infrastructure costs for SSPs except when contributing to co-location of treatment
(funds may be used for additional expenses associated with co-location)
• Provision of equipment solely intended for illegal drug use, such as
syringes, cookers/spoons, syringes, and pipes
• Procurement of other equipment solely intended for preparing drugs for illegal drug
injection, such as sterile water, filters, tourniquets, razors, straws, plastic cards, and
tiny spoons
• Safe injection sites (controlled environments that facilitate safer use of illicit drugs by
providing medical staff, clean facilities, and education) and developing educational
outreach and guidance or materials (including mass media, print, digital, or other)
about supervised injection facilities
• Purchasing and distributing fentanyl test strips for testing in biological samples
for clinical decision-making purposes
• Purchasing basic food, health, or personal items if not intended to support outreach
or engage individuals in venue-based programs (e.g., meal or grocery cards, first aid
kits, hygiene items, clothes, etc.)
• Pharmacy voucher program that provides participants with vouchers redeemable for
free syringes at participating pharmacies
Activities related to public health/public safety:
• Drug disposal, including the implementation or expansion of drug disposal
programs, drug take back programs, drug drop boxes, and drug disposal bags
• Purchase of handheld drug testing machines such as TruNarc, Fourier-transform
infrared (FTIR) machines, or HPMS machines for the purposes of reducing possible law
enforcement exposure to fentanyl
• Public safety activities that do not include overlap/collaboration with public
health partners and objectives
Page 11 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Activities related to health systems:
• Purchasing, leasing, or renting equipment intended to help EMS and other clinicians
treat and manage overdose
• Provision of SUD treatment that includes MOUD and the purchase of medications
such as Methadone, Buprenorphine, and Naltrexone
• Directly funding or expanding the provision of substance use treatment
• Paying for fees associated with clinicians obtaining waived status for DATA
waivers. This applies to direct reimbursements, contracts and waiver fees
• Financial incentives to encourage clinicians to participate in educational sessions
and training activities (e.g., participation in academic detailing, attending seminars,
completion of post-session surveys)
• Paying for the following services (only referral or linkage to them is allowed):
o Treatment for substance use disorder (MOUD)
o Behavioral therapy (e.g., cognitive behavioral therapy)
o Housing assistance
o Food assistance
o Medical care
• Specialized clinical care, if indicated, such as pain management Other generalized,
unallowable activities:
• Funding or subsidizing costs associated with programs other than those
specifically targeting overdose prevention
• Childcare and childcare-related purchases (e.g. pack-n-play)
• Furniture or equipment (purchase or leasing vehicles may be allowable expenses
for linkage to care activities)
• Research
• Prevention of Adverse Childhood Experiences (ACEs) as a standalone activity
Funding cannot be used to directly fund or expand the direct provision of substance use
disorder treatment programs. Such activities are outside the scope of this grant.
Page 12 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Exhibit M
Notice of Award
Page 13 of 14

C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3
Page 14 of 14